Q32 Bio Valuation
| QTTB Stock | 2.04 0.07 3.55% |
Based on Macroaxis valuation methodology, the entity appears to be overvalued. Q32 Bio owns a latest Real Value of USD1.84 per share. The recent price of the entity is USD2.04. Our model determines the value of Q32 Bio from reviewing the entity fundamentals such as return on asset of -0.36, and Price To Book of 3.55 X as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Q32 Bio's price fluctuation is out of control at this time. Calculation of the real value of Q32 Bio is based on 3 months time horizon. Increasing Q32 Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Q32 Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Q32 Stock. However, Q32 Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.04 | Real 1.84 | Hype 2.04 | Naive 2.21 |
The real value of Q32 Stock, also known as its intrinsic value, is the underlying worth of Q32 Bio Company, which is reflected in its stock price. It is based on Q32 Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Q32 Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Q32 Bio helps investors to forecast how Q32 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Q32 Bio more accurately as focusing exclusively on Q32 Bio's fundamentals will not take into account other important factors: Q32 Bio Total Value Analysis
Q32 Bio is at this time anticipated to have valuation of (12.11 M) with market capitalization of 24.03 M, debt of 18.9 M, and cash on hands of . The negative valuation of Q32 Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Q32 Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(12.11 M) | 24.03 M | 18.9 M |
Q32 Bio Asset Utilization
One of the ways to look at asset utilization of Q32 is to check how much profit was generated for every dollar of assets it reports. Q32 Bio owns a negative utilization of current and long term assets of -0.36 %, losing USD0.003595 for each dollar of current and long term assets held by the entity. Inadequate asset utilization implies the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of Q32 Bio shows how discouraging it operates for each dollar spent on its current and long term assets.Q32 Bio Ownership Allocation
The market capitalization of Q32 Bio is USD24.03 Million. Over half of Q32 Bio's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.Q32 Bio Profitability Analysis
Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (48.15 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Q32 Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Q32 Bio and how it compares across the competition.
About Q32 Bio Valuation
The stock valuation mechanism determines Q32 Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Q32 Bio. We calculate exposure to Q32 Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Q32 Bio's related companies.Q32 Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 9.7 M |
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |